Search Results for "Sk Biopharmaceuticals Korea"

17:00 EDT 1st September 2014 | BioPortfolio

Original Source: SK Biopharmaceuticals

SK Biopharmaceuticals, a research and development company specializing in the discovery of small molecule drug candidates and their development from drug target through commercialization will remain in their headquarters in Fairfield, New Jersey. SK Energy & Chemicals, which manufactures and develops fine chemicals, pharmaceutical intermediates, and API's, will remain in their Fair Lawn, New Jersey offices. SK USA is the US headquarters for SK Group, Korea's third largest conglomerate. SK USA develops new ...

Matching Channels

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

BioPortfolio Twitter Accounts

BioPortfolio has created approx 150 Twitter accounts with currently (June 2013 - 25,000 Twitter Followers) to support our users interest in keeping upto date on the latest news, research papers, rep...

Matching News

Keryx Biopharmaceuticals, Inc.: GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation a...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal

NEW YORK, 2014-04-15 14:30 CEST (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of pharma...

Top 10 VC-backed startups in Korea: Kakao still dominates

Under The Radar, a prominent IT and startup-focused blog in Korea, recently published a top 10 list of venture backed enterprises in Korea. Not surprisingly, Kakao placed number one in...

Keryx Biopharmaceuticals, Inc.: Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo

Poster Highlights Potential Pharmacoeconomic Benefit for Managed Care Organizations NEW YORK, 2014-03-17 13:30 CET (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced t...

The ICIST-KAIST International Conference 2014 from August 4-8, 2014 in Korea

(The Korea Advanced Institute of Science and Technology (KAIST)) 'Does science lead progress?' This thought-provoking question will be explored this summer, August 4-8, 2014, with hundreds of universi...

BexPharm Korea to sell MediWound's NexoBrid in South Korea

Fresh off of a $75mm IPO a few months ago, wound and burn care company MediWound Ltd. licensed BexPharm Korea Co. Ltd. (ob/gyn, dermatology, burn/wound, and surgery care therapies) exclusive rights to...

MediWound Expands Distribution of NexoBrid to South Korea Through Agreement With BexPharm Korea

YAVNE, Israel, May 30, 2014 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and woun...

Alder Biopharmaceuticals targets up to $115M from IPO

Alder Biopharmaceuticals said in a regulatory filing that it hopes to secure up to $115 million in an initial public offering -More- 

Matching PubMed Articles

Mini-review: Targeted biopharmaceuticals for cancer treatment.

Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Protein-based biopharmaceuticals have significantly extended the lives of millions of cancer patients. Th...

Placental Transfer of Fc-Containing Biopharmaceuticals across Species, an Industry Survey Analysis.

Understanding species differences in placental transfer of Fc-containing biopharmaceuticals (particularly monoclonal antibodies) will improve human risk extrapolation from nonclinical embryo-fetal dev...

Biopharmaceutical discovery and production in yeast.

The selection of an expression platform for recombinant biopharmaceuticals is often centered upon suitable product titers and critical quality attributes, including post-translational modifications. A...

Contributions to the foliicolous lichens flora of South Korea.

South Korea is covered primarily by temperate vegetation; therefore, foliicolous lichens may not be expected to play an important role in its lichen flora. However, this study describes four foliicolo...

Attitudes toward suicide among college students in South Korea and the United States.

South Korea (hereafter, Korea) has witnessed a rapid increase in its suicide rate over the past few decades and currently reports the highest rate among Organization for Economic Cooperation and Devel...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement